Search
for

    GlossaryBisphosphonates

    drugs that prevent bone density loss by inhibiting osteoclasts

    Bisphosphonates, also known as diphosphonates, are a class of drugs that prevent the loss of bone density. They are commonly prescribed to treat osteoporosis and similar bone diseases by inhibiting the activity of osteoclasts, the cells responsible for bone resorption. This helps to strengthen bones and reduce the risk of fractures.

    Related Terms

    Learn

    0 / 0 results
    — no results

    Research

    5 / 128 results
      Menopause

      research Menopause

      3 citations, January 2007 in “Elsevier eBooks”
      The document concludes that individualized treatment and lifestyle changes are important for managing menopause symptoms and health risks.
      Skin Manifestations of Chronic Kidney Disease

      research Skin Manifestations of Chronic Kidney Disease

      September 2015 in “Actas Dermo-Sifiliográficas”
      People with advanced chronic kidney disease often have skin problems, which can be treated with various medications and procedures to improve their quality of life.
      Wound Healing, Cutaneous Therapy, Hair

      research Wound Healing, Cutaneous Therapy, Hair

      April 2008 in “Medical & surgical dermatology”
      Certain hairstyles can cause scalp diseases, smoking is linked to hair loss, 5% minoxidil foam is effective for hair loss treatment, and various factors influence wound healing and hair growth.
    View more "bisphosphonates" in research →

    Community Join

    0 / 0 results
    — no results